{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:40:41Z","timestamp":1760370041826,"version":"build-2065373602"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010787","name":"Associazione Italiana Rett","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Rett syndrome (RTT) is a severe neurodevelopmental disorder primarily caused by mutations in the X-linked <jats:italic>MECP2<\/jats:italic> gene. Patient-derived fibroblasts serve as a practical system to study systemic aspects of RTT, however, their limited proliferative capacity due to cellular senescence poses a significant challenge. In this study, we establish a robust workflow to isolate and immortalize clonal fibroblast lines from female RTT patients heterozygous for two distinct <jats:italic>MECP2<\/jats:italic> mutations (c.705delG and 1155del32). By employing single-cell cloning prior to hTERT-mediated immortalization, we generated stable, proliferative fibroblast clones with verified clonality and severely skewed X-chromosome inactivation. Wildtype clones exclusively expressed full-length MeCP2 protein, whereas mutant clones exhibit truncated or absent MeCP2. Immortalized lines retained elevated <jats:italic>hTERT<\/jats:italic> expression and sustained proliferation even at late passages. Notably, mutant clones recapitulated key molecular features of RTT, including histone hyperacetylation, dysregulation of oxidative stress markers, and aberrant expression of key signaling genes. Our approach provides a scalable and renewable in vitro model that faithfully captures critical aspects of RTT pathology and offers a complementary platform to existing animal and iPSC based systems. Moreover, the approach is adaptable for studying other X-linked genetic disorders and supports applications in mechanistic research and preclinical drug screening.<\/jats:p>","DOI":"10.1038\/s41598-025-19619-x","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:53:48Z","timestamp":1760363628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimized clonal isolation and immortalization of Rett syndrome patient fibroblasts for in vitro modeling of MECP2\u00a0mutations"],"prefix":"10.1038","volume":"15","author":[{"given":"Victoria","family":"Sarne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Beribisky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hengstschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Laccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Steinkellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"19619_CR1","unstructured":"Orphanet Rett syndrome. https:\/\/www.orpha.net\/en\/disease\/detail\/778"},{"key":"19619_CR2","doi-asserted-by":"publisher","first-page":"1373489","DOI":"10.3389\/frsle.2024.1373489","volume":"3","author":"K Bricker","year":"2024","unstructured":"Bricker, K. & Vaughn, B. V. Rett syndrome: a review of clinical manifestations and therapeutic approaches. Front Sleep 3, 1373489 (2024).","journal-title":"Front Sleep"},{"key":"19619_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185\u2013188 (1999).","journal-title":"Nat. Genet."},{"key":"19619_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng1327","volume":"36","author":"GN Mnatzakanian","year":"2004","unstructured":"Mnatzakanian, G. N. et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36, 339\u2013341 (2004).","journal-title":"Nat. Genet."},{"key":"19619_CR5","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddaa154","volume":"29","author":"DC Rodrigues","year":"2020","unstructured":"Rodrigues, D. C., Mufteev, M. & Ellis, J. Regulation, diversity and function of MECP2 exon and 3\u2019UTR isoforms. Hum. Mol. Genet. 29, R89\u2013R99 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"19619_CR6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/nar\/gkh349","volume":"32","author":"S Kriaucionis","year":"2004","unstructured":"Kriaucionis, S. & Bird, A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818\u20131823 (2004).","journal-title":"Nucleic Acids Res."},{"key":"19619_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41597-020-00794-7","volume":"8","author":"F Ehrhart","year":"2021","unstructured":"Ehrhart, F. et al. A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration. Sci. Data. 8, 10 (2021).","journal-title":"Sci. Data"},{"key":"19619_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","volume":"51","author":"VA Cuddapah","year":"2014","unstructured":"Cuddapah, V. A. et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J. Med. Genet. 51, 152\u2013158 (2014).","journal-title":"J. Med. Genet."},{"key":"19619_CR9","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1038\/s41598-019-48385-w","volume":"9","author":"C Xiol","year":"2019","unstructured":"Xiol, C. et al. X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients. Sci. Rep. 9, 11983 (2019).","journal-title":"Sci. Rep."},{"key":"19619_CR10","first-page":"1142","volume":"329","author":"E Harris","year":"2023","unstructured":"Harris, E. Trofinetide receives FDA approval as first drug for Rett syndrome. JAMA 329, 1142 (2023).","journal-title":"JAMA"},{"key":"19619_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40265-023-01883-8","volume":"83","author":"SJ Keam","year":"2023","unstructured":"Keam, S. J. Trofinetide: First Approval. Drugs 83, 819\u2013824 (2023).","journal-title":"Drugs"},{"key":"19619_CR12","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","volume":"29","author":"JL Neul","year":"2023","unstructured":"Neul, J. L. et al. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat. Med. 29, 1468\u20131475 (2023).","journal-title":"Nat. Med."},{"key":"19619_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","volume":"27","author":"RZ Chen","year":"2001","unstructured":"Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327\u2013331 (2001).","journal-title":"Nat. Genet."},{"key":"19619_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322\u2013326 (2001).","journal-title":"Nat. Genet."},{"key":"19619_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awl022","volume":"129","author":"GJ Pelka","year":"2006","unstructured":"Pelka, G. J. et al. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129, 887\u2013898 (2006).","journal-title":"Brain"},{"key":"19619_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.08.039","volume":"1180","author":"A Lawson-Yuen","year":"2007","unstructured":"Lawson-Yuen, A. et al. Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res. 1180, 1\u20136 (2007).","journal-title":"Brain Res."},{"key":"19619_CR17","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddv030","volume":"24","author":"MR Pitcher","year":"2015","unstructured":"Pitcher, M. R. et al. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene. Hum. Mol. Genet. 24, 2662\u20132672 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"19619_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/hmg\/ddv496","volume":"25","author":"K Brown","year":"2016","unstructured":"Brown, K. et al. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum. Mol. Genet. 25, 558\u2013570 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"19619_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","volume":"143","author":"MCN Marchetto","year":"2010","unstructured":"Marchetto, M. C. N. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527\u2013539 (2010).","journal-title":"Cell"},{"key":"19619_CR20","doi-asserted-by":"publisher","first-page":"14491","DOI":"10.3390\/ijms232214491","volume":"23","author":"S Perego","year":"2022","unstructured":"Perego, S. et al. Modeling RTT Syndrome by iPSC-Derived Neurons from Male and Female Patients with Heterogeneously Severe Hot-Spot MECP2 Variants. Int J. Mol. Sci 23, 14491 (2022).","journal-title":"Int J. Mol. Sci"},{"key":"19619_CR21","doi-asserted-by":"publisher","first-page":"610427","DOI":"10.3389\/fcell.2020.610427","volume":"8","author":"AR Gomes","year":"2020","unstructured":"Gomes, A. R. et al. Modeling Rett syndrome with human Patient-Specific forebrain organoids. Front. Cell. Dev. Biol. 8, 610427 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"19619_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00018-024-05409-7","volume":"81","author":"N Bahram Sangani","year":"2024","unstructured":"Bahram Sangani, N. et al. Involvement of extracellular vesicle MicroRNA clusters in developing healthy and Rett syndrome brain organoids. Cell. Mol. Life Sci. 81, 410 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"19619_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2350-3-12","volume":"3","author":"J Traynor","year":"2002","unstructured":"Traynor, J., Agarwal, P., Lazzeroni, L. & Francke, U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med. Genet. 3, 12 (2002).","journal-title":"BMC Med. Genet."},{"key":"19619_CR24","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1016\/j.bmcl.2011.07.053","volume":"21","author":"D Yu","year":"2011","unstructured":"Yu, D., Sakurai, F. & Corey, D. R. Clonal Rett syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. Bioorg. Med. Chem. Lett. 21, 5202\u20135205 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"19619_CR25","doi-asserted-by":"publisher","first-page":"195935","DOI":"10.1155\/2014\/195935","volume":"2014","author":"C Signorini","year":"2014","unstructured":"Signorini, C. et al. Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome. Oxid. Med. Cell. Longev. 2014, 195935 (2014).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"19619_CR26","doi-asserted-by":"publisher","first-page":"137629","DOI":"10.1155\/2013\/137629","volume":"2013","author":"A Pecorelli","year":"2013","unstructured":"Pecorelli, A. et al. Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients. Mediators Inflamm. 2013, 137629 (2013).","journal-title":"Mediators Inflamm."},{"key":"19619_CR27","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/hmg\/ddr093","volume":"20","author":"AYL Cheung","year":"2011","unstructured":"Cheung, A. Y. L. et al. Isolation of MECP2-null Rett syndrome patient hips cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 20, 2103\u20132115 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"19619_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1749-6632.2012.06611.x","volume":"1259","author":"C De Felice","year":"2012","unstructured":"De Felice, C. et al. The role of oxidative stress in Rett syndrome: an overview. Ann. N Y Acad. Sci. 1259, 121\u2013135 (2012).","journal-title":"Ann. N Y Acad. Sci."},{"key":"19619_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell. Res. 25, 585\u2013621 (1961).","journal-title":"Exp. Cell. Res."},{"key":"19619_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0092-8674(00)80538-3","volume":"90","author":"M Meyerson","year":"1997","unstructured":"Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785\u2013795 (1997).","journal-title":"Cell"},{"key":"19619_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/hmg\/10.10.1085","volume":"10","author":"M Wan","year":"2001","unstructured":"Wan, M., Zhao, K., Lee, S. S. & Francke, U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum. Mol. Genet. 10, 1085\u20131092 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"19619_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"M Shahbazian","year":"2002","unstructured":"Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243\u2013254 (2002).","journal-title":"Neuron"},{"key":"19619_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.ijbiomac.2022.04.080","volume":"209","author":"H Steinkellner","year":"2022","unstructured":"Steinkellner, H. et al. TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome. Int. J. Biol. Macromol. 209, 972\u2013983 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"19619_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/scd.2023.0233","volume":"33","author":"A Huber","year":"2024","unstructured":"Huber, A. et al. Generation and characterization of a human neuronal in vitro model for Rett syndrome using a direct reprogramming method. Stem Cells Dev. 33, 128\u2013142 (2024).","journal-title":"Stem Cells Dev."},{"issue":"Suppl 1","key":"19619_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0387-7604(01)00369-2","volume":"23","author":"C Sierra","year":"2001","unstructured":"Sierra, C. et al. Oxidative stress in Rett syndrome. Brain Dev. 23 (Suppl 1), 236\u2013239 (2001).","journal-title":"Brain Dev."},{"key":"19619_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2009.05.016","volume":"47","author":"C De Felice","year":"2009","unstructured":"De Felice, C. et al. Systemic oxidative stress in classic Rett syndrome. Free Radic Biol. Med. 47, 440\u2013448 (2009).","journal-title":"Free Radic Biol. Med."},{"key":"19619_CR37","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.abb.2023.109860","volume":"752","author":"A Pasqui","year":"2024","unstructured":"Pasqui, A. et al. A proteomic approach to investigate the role of the MECP2 gene mutation in Rett syndrome redox regulatory pathways. Arch. Biochem. Biophys. 752, 109860 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"19619_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.46582\/jsrm.0803009","volume":"8","author":"C Maucksch","year":"2012","unstructured":"Maucksch, C. et al. Non-Viral generation of neural Precursor-like cells from adult human fibroblasts. J. Stem Cells Regen Med. 8, 162\u2013170 (2012).","journal-title":"J. Stem Cells Regen Med."},{"key":"19619_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4161\/epi.23752","volume":"8","author":"T Lilja","year":"2013","unstructured":"Lilja, T. et al. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients. Epigenetics 8, 246\u2013251 (2013).","journal-title":"Epigenetics"},{"key":"19619_CR40","doi-asserted-by":"publisher","first-page":"14169","DOI":"10.1073\/pnas.1018979108","volume":"108","author":"KY Kim","year":"2011","unstructured":"Kim, K. Y., Hysolli, E. & Park, I. H. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc. Natl. Acad. Sci. USA. 108, 14169\u201314174 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19619_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349\u2013352 (1998).","journal-title":"Science"},{"key":"19619_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/5063","volume":"21","author":"CP Morales","year":"1999","unstructured":"Morales, C. P. et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115\u2013118 (1999).","journal-title":"Nat. Genet."},{"key":"19619_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","volume":"37","author":"PJ Skene","year":"2010","unstructured":"Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell. 37, 457\u2013468 (2010).","journal-title":"Mol. Cell."},{"key":"19619_CR44","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1124000","volume":"311","author":"M Shogren-Knaak","year":"2006","unstructured":"Shogren-Knaak, M. et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844\u2013847 (2006).","journal-title":"Science"},{"key":"19619_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0092-8674(02)01077-2","volume":"111","author":"T Agalioti","year":"2002","unstructured":"Agalioti, T., Chen, G. & Thanos, D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111, 381\u2013392 (2002).","journal-title":"Cell"},{"key":"19619_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/30764","volume":"393","author":"X Nan","year":"1998","unstructured":"Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386\u2013389 (1998).","journal-title":"Nature"},{"key":"19619_CR47","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41594-024-01374-8","volume":"31","author":"Dynamics of an epigenetic","year":"2024","unstructured":"Dynamics of an epigenetic. Regulator on chromatin observed at the single-molecule level. Nat. Struct. Mol. Biol. 31, 1648\u20131649 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"19619_CR48","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224\u20131229 (2008).","journal-title":"Science"},{"key":"19619_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00018-003-3206-5","volume":"61","author":"P Chelikani","year":"2004","unstructured":"Chelikani, P., Fita, I. & Loewen, P. C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 61, 192\u2013208 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"19619_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","volume":"64","author":"I Fridovich","year":"1995","unstructured":"Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97\u2013112 (1995).","journal-title":"Annu. Rev. Biochem."},{"key":"19619_CR51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/01.RES.0000121104.05977.F3","volume":"94","author":"J Haendeler","year":"2004","unstructured":"Haendeler, J. et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 94, 768\u2013775 (2004).","journal-title":"Circ. Res."},{"key":"19619_CR52","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1242\/jcs.019372","volume":"121","author":"S Ahmed","year":"2008","unstructured":"Ahmed, S. et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell. Sci. 121, 1046\u20131053 (2008).","journal-title":"J. Cell. Sci."},{"key":"19619_CR53","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jcyt.2017.03.078","volume":"19","author":"V Trachana","year":"2017","unstructured":"Trachana, V. et al. Human mesenchymal stem cells with enhanced telomerase activity acquire resistance against oxidative stress-induced genomic damage. Cytotherapy 19, 808\u2013820 (2017).","journal-title":"Cytotherapy"},{"key":"19619_CR54","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbalip.2018.08.006","volume":"1864","author":"Y Kita","year":"2019","unstructured":"Kita, Y., Shindou, H. & Shimizu, T. Cytosolic phospholipase A2 and lysophospholipid acyltransferases. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1864, 838\u2013845 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"19619_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neures.2017.07.007","volume":"129","author":"H Bannai","year":"2018","unstructured":"Bannai, H. Molecular membrane dynamics: insights into synaptic function and neuropathological disease. Neurosci. Res. 129, 47\u201356 (2018).","journal-title":"Neurosci. Res."},{"key":"19619_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ame2.12236","volume":"5","author":"S Lu","year":"2022","unstructured":"Lu, S., Chen, Y. & Wang, Z. Advances in the pathogenesis of Rett syndrome using cell models. Anim. Models Exp. Med. 5, 532\u2013541 (2022).","journal-title":"Anim. Models Exp. Med."},{"key":"19619_CR57","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1152\/physrev.2000.80.4.1291","volume":"80","author":"MJ Rebecchi","year":"2000","unstructured":"Rebecchi, M. J. & Pentyala, S. N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80, 1291\u20131335 (2000).","journal-title":"Physiol. Rev."},{"key":"19619_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1359-6101(96)00053-6","volume":"8","author":"DR Clemmons","year":"1997","unstructured":"Clemmons, D. R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor. Rev. 8, 45\u201362 (1997).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"19619_CR59","first-page":"9.7.1","volume":"80","author":"JR Jones","year":"2014","unstructured":"Jones, J. R. Nonrandom X chromosome inactivation detection. Curr Protoc. Hum. Gent. 80,\u00a09.7.1\u20139.7.7 (2014).","journal-title":"Curr Protoc. Hum. Genet"},{"key":"19619_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19619-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:19:37Z","timestamp":1760368777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19619-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19619"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19619-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35696"}}